Ranked #1 in 8 out of the 10 evaluated specialties by U.S. News
MyPatients provides referring primary care providers with secure access to their patients’ information.
Boston Children's has launched the world's 1st program dedicated to offering hand transplants to children who qualify.
Innovation insider is a semi-monthly e-newsletter analyzes innovations at Boston Children’s, other academic medical centers and from industry.
Read the latest blog by a Boston Children's doctor, clinician or staff member.
Support the hospital with a donation that helps kids get the care they need.
The Division of Genetics and Genomics at Boston Children’s Hospital has discovery and innovation built into its DNA. Our Clinical Genetics Program and research laboratories work closely together to find the underlying causes of inherited disorders and to use this knowledge to provide better care and counseling.
Rapid technological advances in genetics and genomics are allowing our researchers to find extremely subtle mutations—some affecting as few as 10 percent of the body’s cells—and to spot differences in gene activity that may contribute to disease.
These advances are helping us solve patients’ diagnostic mysteries, understand disease biology and find new treatments—sometimes ones that wouldn’t otherwise be considered. Today, it’s truly possible to go from genetic discovery to clinical trial within a decade.
Our initiatives range from a study sequencing the genomes of newborns to in-depth rare-disease research at our Manton Center for Orphan Disease Research to an international contest seeking the best practices for providing DNA sequencing results to doctors, patients and families.
Families can help further genetic discovery too! Ask your geneticist or genetic counselor if there are any studies you or your child might be eligible to join, or visit our Clinical Studies page.
For more about our research and innovations, visit our Genetics and Genomics Research site.
The future of pediatrics will be forged by thinking differently, breaking paradigms and joining together in a shared vision of tackling the toughest challenges before us.”